Clinical Trials List
2022-09-01 - 2025-12-31
Phase I
Recruiting7
Terminated1
-
-
Trial Applicant
AbbVie
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/15
Investigators and Locations
Co-Principal Investigator
- Chih-Yen Tu 未分科
- 陳鴻仁 未分科
- Yu-Chao Lin 未分科
- Chia-Hsiang Li 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Hung Luo 未分科
- Heng-Sheng Chao 未分科
- YEN-HAN TSENG 未分科
- Hsu-ching Huang 未分科
- Chia-I Shen 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jen-Shi Chen 未分科
- 曾振輝 未分科
- 黃文冠 未分科
- 吳教恩 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
36 participants
-
Global
500 participants